A citation-based method for searching scientific literature

Marina N Nikiforova, Roy A Lynch, Paul W Biddinger, Erik K Alexander, Gerald W Dorn, Giovanni Tallini, Todd G Kroll, Yuri E Nikiforov. J Clin Endocrinol Metab 2003
Times Cited: 472







List of co-cited articles
1210 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
32

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A Knauf, Ronak H Shah, Snjezana Dogan, Julio C Ricarte-Filho, Gnana P Krishnamoorthy, Bin Xu,[...]. J Clin Invest 2016
464
26

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors.
Yuri E Nikiforov, Raja R Seethala, Giovanni Tallini, Zubair W Baloch, Fulvio Basolo, Lester D R Thompson, Justine A Barletta, Bruce M Wenig, Abir Al Ghuzlan, Kennichi Kakudo,[...]. JAMA Oncol 2016
738
24

Molecular genetics and diagnosis of thyroid cancer.
Yuri E Nikiforov, Marina N Nikiforova. Nat Rev Endocrinol 2011
568
22

PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].
T G Kroll, P Sarraf, L Pecciarini, C J Chen, E Mueller, B M Spiegelman, J A Fletcher. Science 2000
622
19


Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease.
Iñigo Landa, Ian Ganly, Timothy A Chan, Norisato Mitsutake, Michiko Matsuse, Tihana Ibrahimpasic, Ronald A Ghossein, James A Fagin. J Clin Endocrinol Metab 2013
258
18

Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase/akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers.
Zhi Liu, Peng Hou, Meiju Ji, Haixia Guan, Kimberly Studeman, Kirk Jensen, Vasily Vasko, Adel K El-Naggar, Mingzhao Xing. J Clin Endocrinol Metab 2008
273
17

Prevalence of Ras mutations in thyroid neoplasia.
C T Esapa, S J Johnson, P Kendall-Taylor, T W Lennard, P E Harris. Clin Endocrinol (Oxf) 1999
162
17

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Rui Batista, Joana Peixoto, Catarina Tavares, Ricardo Celestino, Ana Almeida, Catarina Salgado, Catarina Eloy,[...]. J Clin Endocrinol Metab 2014
303
17

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.
Julio C Ricarte-Filho, Mabel Ryder, Dhananjay A Chitale, Michael Rivera, Adriana Heguy, Marc Ladanyi, Manickam Janakiraman, David Solit, Jeffrey A Knauf, R Michael Tuttle,[...]. Cancer Res 2009
352
16

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.
Paula Soares, Vítor Trovisco, Ana Sofia Rocha, Jorge Lima, Patrícia Castro, Ana Preto, Valdemar Máximo, Tiago Botelho, Raquel Seruca, Manuel Sobrinho-Simões. Oncogene 2003
489
16

Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
Ana Rita Marques, Carla Espadinha, Ana L Catarino, Sónia Moniz, Teresa Pereira, Luís G Sobrinho, Valeriano Leite. J Clin Endocrinol Metab 2002
240
16

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
382
16

Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.
Ian Ganly, Julio Ricarte Filho, Stephanie Eng, Ronald Ghossein, Luc G T Morris, Yupu Liang, Nicholas Socci, Kasthuri Kannan, Qianxing Mo, James A Fagin,[...]. J Clin Endocrinol Metab 2013
101
16

Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
Erik K Alexander, Giulia C Kennedy, Zubair W Baloch, Edmund S Cibas, Darya Chudova, James Diggans, Lyssa Friedman, Richard T Kloos, Virginia A LiVolsi, Susan J Mandel,[...]. N Engl J Med 2012
673
15

Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.
Yuri E Nikiforov, N Paul Ohori, Steven P Hodak, Sally E Carty, Shane O LeBeau, Robert L Ferris, Linwah Yip, Raja R Seethala, Mitchell E Tublin, Michael T Stang,[...]. J Clin Endocrinol Metab 2011
497
15

Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas.
Adebowale J Adeniran, Zhaowen Zhu, Manoj Gandhi, David L Steward, James P Fidler, Thomas J Giordano, Paul W Biddinger, Yuri E Nikiforov. Am J Surg Pathol 2006
336
15

BRAF mutation in thyroid cancer.
M Xing. Endocr Relat Cancer 2005
897
15

Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer.
Peng Hou, Dingxie Liu, Yuan Shan, Shuiying Hu, Kimberley Studeman, Stephen Condouris, Yangang Wang, Ariel Trink, Adel K El-Naggar, Giovanni Tallini,[...]. Clin Cancer Res 2007
273
15

PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.
Marina N Nikiforova, Paul W Biddinger, Christy M Caudill, Todd G Kroll, Yuri E Nikiforov. Am J Surg Pathol 2002
234
15

TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
178
15

Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer.
Lindsey M Kelly, Guillermo Barila, Pengyuan Liu, Viktoria N Evdokimova, Sumita Trivedi, Federica Panebianco, Manoj Gandhi, Sally E Carty, Steven P Hodak, Jianhua Luo,[...]. Proc Natl Acad Sci U S A 2014
156
14

Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
David S Cooper, Gerard M Doherty, Bryan R Haugen, Richard T Kloos, Stephanie L Lee, Susan J Mandel, Ernest L Mazzaferri, Bryan McIver, Furio Pacini, Martin Schlumberger,[...]. Thyroid 2009
14

Genetic and biological subgroups of low-stage follicular thyroid cancer.
Christopher A French, Erik K Alexander, Edmund S Cibas, Vania Nose, Julia Laguette, William Faquin, Jeff Garber, Francis Moore, Jonathan A Fletcher, P Reed Larsen,[...]. Am J Pathol 2003
111
14

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
363
14


Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors.
Trisha Dwight, Srinivasan R Thoppe, Theodoros Foukakis, Weng O Lui, Göran Wallin, Anders Höög, Tony Frisk, Catharina Larsson, Jan Zedenius. J Clin Endocrinol Metab 2003
147
13

Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer.
Marina N Nikiforova, Abigail I Wald, Somak Roy, Mary Beth Durso, Yuri E Nikiforov. J Clin Endocrinol Metab 2013
287
12

Molecular genotyping of papillary thyroid carcinoma follicular variant according to its histological subtypes (encapsulated vs infiltrative) reveals distinct BRAF and RAS mutation patterns.
Michael Rivera, Julio Ricarte-Filho, Jeff Knauf, Ashok Shaha, Michael Tuttle, James A Fagin, Ronald A Ghossein. Mod Pathol 2010
245
12

ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.
Ginesa Garcia-Rostan, Hongyu Zhao, Robert L Camp, Marina Pollan, Agustin Herrero, Javier Pardo, Ran Wu, Maria Luisa Carcangiu, Jose Costa, Giovanni Tallini. J Clin Oncol 2003
261
12

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
158
12

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.
Yuri E Nikiforov, Sally E Carty, Simon I Chiosea, Christopher Coyne, Umamaheswar Duvvuri, Robert L Ferris, William E Gooding, Steven P Hodak, Shane O LeBeau, N Paul Ohori,[...]. Cancer 2014
304
11

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas.
Marina N Nikiforova, Edna T Kimura, Manoj Gandhi, Paul W Biddinger, Jeffrey A Knauf, Fulvio Basolo, Zhaowen Zhu, Riccardo Giannini, Giuliana Salvatore, Alfredo Fusco,[...]. J Clin Endocrinol Metab 2003
746
11

Specific pattern of RAS oncogene mutations in follicular thyroid tumors.
V Vasko, M Ferrand, J Di Cristofaro, P Carayon, J F Henry, C de Micco. J Clin Endocrinol Metab 2003
229
11

Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
Tetsuo Kondo, Shereen Ezzat, Sylvia L Asa. Nat Rev Cancer 2006
621
11


The associations between RAS mutations and clinical characteristics in follicular thyroid tumors: new insights from a single center and a large patient cohort.
Michiko Fukahori, Akira Yoshida, Hiroyuki Hayashi, Mitsuyo Yoshihara, Shoichi Matsukuma, Yuji Sakuma, Shiro Koizume, Naoyuki Okamoto, Tetsuo Kondo, Munetake Masuda,[...]. Thyroid 2012
80
13

NRAS codon 61 mutation is associated with distant metastasis in patients with follicular thyroid carcinoma.
Eun Kyung Jang, Dong Eun Song, So Young Sim, Hyemi Kwon, Yun Mi Choi, Min Ji Jeon, Ji Min Han, Won Gu Kim, Tae Yong Kim, Young Kee Shong,[...]. Thyroid 2014
53
20

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.
John W Kunstman, C Christofer Juhlin, Gerald Goh, Taylor C Brown, Adam Stenman, James M Healy, Jill C Rubinstein, Murim Choi, Nimrod Kiss, Carol Nelson-Williams,[...]. Hum Mol Genet 2015
181
11

Comprehensive Analysis of the Transcriptional and Mutational Landscape of Follicular and Papillary Thyroid Cancers.
Seong-Keun Yoo, Seungbok Lee, Su-Jin Kim, Hyeon-Gun Jee, Byoung-Ae Kim, Hyesun Cho, Young Shin Song, Sun Wook Cho, Jae-Kyung Won, Jong-Yeon Shin,[...]. PLoS Genet 2016
145
11

Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Hyeyeun Lim, Susan S Devesa, Julie A Sosa, David Check, Cari M Kitahara. JAMA 2017
732
11

Biologic and Clinical Perspectives on Thyroid Cancer.
James A Fagin, Samuel A Wells. N Engl J Med 2016
313
11

Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
Emmanuel Labourier, Alexander Shifrin, Anne E Busseniers, Mark A Lupo, Monique L Manganelli, Bernard Andruss, Dennis Wylie, Sylvie Beaudenon-Huibregtse. J Clin Endocrinol Metab 2015
150
10

The role of microRNA genes in papillary thyroid carcinoma.
Huiling He, Krystian Jazdzewski, Wei Li, Sandya Liyanarachchi, Rebecca Nagy, Stefano Volinia, George A Calin, Chang-Gong Liu, Kaarle Franssila, Saul Suster,[...]. Proc Natl Acad Sci U S A 2005
926
10

The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis.
Massimo Bongiovanni, Alessandra Spitale, William C Faquin, Luca Mazzucchelli, Zubair W Baloch. Acta Cytol 2012
485
10

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF.
Paul T C Wan, Mathew J Garnett, S Mark Roe, Sharlene Lee, Dan Niculescu-Duvaz, Valerie M Good, C Michael Jones, Christopher J Marshall, Caroline J Springer, David Barford,[...]. Cell 2004
10

RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers.
Nikhil Gupta, Anil K Dasyam, Sally E Carty, Marina N Nikiforova, N Paul Ohori, Michaele Armstrong, Linwah Yip, Shane O LeBeau, Kelly L McCoy, Christopher Coyne,[...]. J Clin Endocrinol Metab 2013
96
10

PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
P Castro, A P Rebocho, R J Soares, J Magalhães, L Roque, V Trovisco, I Vieira de Castro, M Cardoso-de-Oliveira, E Fonseca, P Soares,[...]. J Clin Endocrinol Metab 2006
193
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.